Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.

MLA

Hwang, N., et al. “Massive Endoprosthetic Replacement for Bone Metastases Resulting from Renal Cell Carcinoma: Factors Influencing Patient Survival.” European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 40, no. 4, Apr. 2014, pp. 429–34. EBSCOhost, https://doi.org/10.1016/j.ejso.2013.08.001.

APA

Hwang, N., Nandra, R., Grimer, R. J., Carter, S. R., Tillman, R. M., Abudu, A., & Jeys, L. M. (2014). Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival. European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 40(4), 429–434. https://doi.org/10.1016/j.ejso.2013.08.001

Chicago

Hwang, N, R Nandra, R J Grimer, S R Carter, R M Tillman, A Abudu, and L M Jeys. 2014. “Massive Endoprosthetic Replacement for Bone Metastases Resulting from Renal Cell Carcinoma: Factors Influencing Patient Survival.” European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 40 (4): 429–34. doi:10.1016/j.ejso.2013.08.001.